Objective: Determine if interactive, case-based, online continuing medical education (CME) improves the competence and confidence of diabetologists/endocrinologists (D/Es) and pediatricians on staging T1D. Methods: Educational design included a “test, then teach” approach to elicit cognitive dissonance, with evidence-based feedback provided following each learner response. A repeated pairs pre-/post-assessment study design and a McNemar’s test (P <.05 is considered significant) assessed educational effect, with Cohen’s d being used to assess educational impact (<0.2 modest effect, 0.2-0.49 small effect, 0.5-0.79 moderate effect and >0.8 extensive effect). The activity launched July 29, 2022 and data were collected through October 6, 2022.
Results: 77 D/Es and 160 pediatricians were included in the analysis. Matched learner data indicate that overall, 77% D/Es and 76% of pediatricians improved their competence from pre-to-post (both P<.0001 with extensive overall impacts in both groups 0.9-1.06) On a question-level: 56% of D/Es (P<.001) and 48% of pediatricians (P<.001) improved at appropriate screening of high-risk patients for T1D 27% of D/Es (P<.001) and 31% of pediatricians (P<.001) improved at educating caregivers about screening of siblings at risk of T1D 51% of D/Es (P<.001) and 51% of pediatricians (P<.001) improved at staging of patients with T1D based on test results Overall, 60% of D/Es and 61% of pediatricians reported increased confidence in staging patients with T1D, for an overall confidence shift of +75% in D/Es and +96% in pediatricians with increased confidence.
Conclusion: Interactive, case-based, online CME is successful at improving competence and confidence of D/Es and pediatricians related to staging of at-risk patients for T1D. Case-based education with interactive polling questions and detailed explanations related to best choices should be employed more often to help clinicians apply guidelines into practice to improve patient care.
A.Larkin: None. A.Le: None.
Provention Bio, Inc.
